Bottom line
PRHSX vs PHLAX: the short answer
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and PHLAX (PGIM Jennison Health Sciences Fund) share a meaningful slice of their top holdings — about 52% by weight.
But PRHSX is far broader, holding 279 positions to 55 for PHLAX, so beyond the top names it adds exposure PHLAX doesn't have.
PRHSX is cheaper at 0.83% vs 1.15% — a difference of $32 a year per $10,000 invested.
Over five years, PHLAX returned +5.5% a year vs +4.2% for PRHSX (reporting dates differ).
PHLAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
PRHSX vs PHLAX side by side
| PRHSX | PHLAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | T. Rowe Price | PGIM (Prudential) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.83% | 1.15% |
| Annual cost per $10k | $83 | $115 |
| 10-yr cost on $10k (prospectus) | $1,025 | $1,871 |
| Max front load | — | 5.5% |
| 12b-1 fee | — | 0.3% |
| 1-yr return | +17.7% | +12.7% |
| 5-yr return (annualized) | +4.2% | +5.5% |
| 10-yr return (annualized) | +9.1% | +8.9% |
| Best quarter | +23.5% | — |
| Worst quarter | −15.8% | — |
| Net assets (fund) | $11.9B | $1.4B |
| Number of holdings | 279 | 55 |
| Portfolio turnover | 62% | 81% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
9 of PRHSX's top 25 holdings also appear in PHLAX's top 25.
| Holding | PRHSX | PHLAX |
|---|---|---|
| Eli Lilly & Co | 14.28% | 17.35% |
| Unitedhealth Group Inc | 5.99% | 5.87% |
| Merck & Co. Inc. | 4.01% | 6.06% |
| Thermo Fisher Scientific Inc | 2.52% | 4.56% |
| Vertex Pharmaceuticals Inc | 2.28% | 3.37% |
| Intuitive Surgical Inc | 1.87% | 3.07% |
| Stryker Corp | 1.78% | 2.16% |
| Danaher Corp | 1.43% | 3.28% |
| Cvs Health Corp | 0.94% | 2.52% |
Source: SEC Form N-PORT
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
PHLAX top 10
- Eli Lilly & Company — 17.35%
- Merck & Company Inc — 6.06%
- Unitedhealth Group Inc — 5.87%
- Thermo Fisher Scientific Inc — 4.56%
- Argenx Se — 3.55%
- Vertex Pharmaceuticals Inc — 3.37%
- Danaher Corp — 3.28%
- Intuitive Surgical Inc — 3.07%
- Lonza Group Ag — 3.02%
- Cvs Health Corp — 2.52%
FAQ
What is the difference between PRHSX and PHLAX?
Which is cheaper, PRHSX or PHLAX?
Should I own both PRHSX and PHLAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.